SCHEMBL8021280

SCHEMBL8021280

CCOC(=O)CNC(=O)[C@@H](N)CC(C)C

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
SLC7A5 Q01650 1/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
PPID Q08752 2/20 0.39
PPIB P23284 1/20 0.39
PPIA P62937 1/20 0.39
PPIG Q13427 1/20 0.39
ANPEP P15144 2/20 0.39
RNPEP Q9H4A4 2/20 0.39
DNPEP Q9ULA0 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
LARS1 Q9P2J5 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021278 1.00 GAA (0.45) GAASLC7A5MGAMSIMGAM2
Bromide SCHEMBL9807038 0.98 GAA (0.44) GAASLC7A5MGAMSIMGAM2
Hydrochloric Acid SCHEMBL9807062 0.98 GAA (0.44) GAASLC7A5MGAMSIMGAM2
SCHEMBL10954445 0.84 SLC7A5 (0.45) SLC7A5ANPEPRNPEPDNPEPTSHR
SCHEMBL14031294 0.84 GAA (0.49) GAAMGAMSIMGAM2PPID
SCHEMBL10954441 0.84 SLC7A5 (0.45) SLC7A5ANPEPRNPEPDNPEPTSHR
SCHEMBL5494766 0.84 ANPEP (0.41) GAASLC7A5MGAMSIMGAM2
SCHEMBL5494763 0.84 ANPEP (0.41) GAASLC7A5MGAMSIMGAM2
SCHEMBL29907351 0.83 GAA (0.45) GAAMGAMSIMGAM2PPID
Hydrochloric Acid SCHEMBL10790535 0.83 SLC7A5 (0.44) SLC7A5ANPEPRNPEPDNPEPTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10207990-B2 Salts and prodrugs of 1-methyl-D-tryptophan NEWLINK GENETICS CORPORATION (US) 2019-02-19 US disclosed
US-20180134658-A1 SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN LUMOS PHARMA, INC. 2018-05-17 US disclosed
EP-0985932-A1 METHOD FOR EXAMINING CHRONIC REJECTION REACTIONS FOLLOWING ORGAN TRANSPLANTATION AND METHOD FOR DETERMINING URINE COMPONENTS NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2000-03-15 EP disclosed
US-4545810-A Herbicidal and plant growth regulant diphenylpyridazinones SDS BIOTECH CORPORATION (US) 1985-10-08 US disclosed
WO-1982000402-A1 HERBICIDAL AND PLANT GROWTH REGULANT DIPHENYLPYRIDAZINONES DIAMOND SHAMROCK CORP (US) 1982-02-18 WO disclosed
EP-0046069-A1 Herbicidal and plant growth regulant diphenylpyridazinones DIAMOND SHAMROCK CORPORATION (US) 1982-02-17 EP disclosed
US-RE30496-E Tripeptide derivatives with central nervous system activity and preparation thereof AYERST, MCKENNA & HARRISON, LTD. (CA) 1981-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10207990-B2 Salts and prodrugs of 1-methyl-D-tryptophan IDO1, IDO2, INMT GAA 3198/4885SLC7A5 371/4885MGAM 1778/4885
US-20180134658-A1 SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN IDO1, IDO2, INMT GAA 3198/4885SLC7A5 371/4885MGAM 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.